Novartis India is planning to buyback its equity shares. The meeting of the Board of Directors of the Company will be held on September 25, 2017, to consider the same proposal, constitution of buyback committee, and appointment of intermediaries in accordance with all applicable provisions of law.
Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
